Integration of human papillomavirus (HPV)DNA
Introduction
Cancer development is a multifactorial and multistep process in which sequential genetic changes accumulate causing the activation of cellular proto-oncogenes and the loss or inactivation of tumour suppressor genes (Vogelstein and Kinzler, 1993; Lanfrancone et al., 1994) . In addition, viruses play an essential role as initiators and drivers of the tumorigenic process in some types of human tumours (zur Hausen, 1996) . Human papillomaviruses (HPV) are causally involved in the genesis of cervical carcinomas (zur Hausen, 1994) . Types HPV16 and HPV18 are the prototypes of the cancer-associated papillomaviruses, but other related HPV types have also been detected in malignant tumours and cell lines.
The oncogenic potential of HPV16 and HPV18 has been attributed primarily to the two early genes, E6 and E7. Their products are multifunctional immortalizing and growth-promoting proteins. Major pathways by which they interfere with normal cell regulation are the inactivation of two key tumour suppressors, the p53 protein (by E6) and the retinoblastoma gene product pRB (by E7) (HoppeSeyler and Scheffner, 1997; Tommasino and JansenDuerr, 1997) .
In addition to HPV infection and viral oncogene expression, mutations of host cell genes have to accumulate for a fully malignant phenotype of cervical epithelial cells. The detection of chromosome losses and aberrations and of losses of allele heterozygosity reflect the requirement for multiple genetic changes in cervical carcinogenesis (Mullokandov et al., 1996) . However, the human genes involved have still to be identified.
The HPV DNA genome persists as an extrachromosomal episome in the nucleus of the infected non-malignant cells. In cancer cells and cell lines, however, the viral DNA is found integrated into the host cell genome. Integration can occur into different chromosomal locations with a preference for fragile sites and near oncogenes such as the myc genes (Cannizzaro et al., 1988; Couturier et al., 1991) .
Integration of HPV DNA is considered to be an important step in cervical carcinogenesis. Recent studies supporting this view have shown that integration leads to increased stability of the mRNAs encoding the viral E6 and E7 oncogenes , to increased levels of viral oncogene expression and selective growth advantage of the cells . Conversely, expression of the E6 and E7 oncogenes has been shown to result in an increased frequency of DNA integration (Kessis et al., 1996) .
In the integrated HPV genomes, the early region which harbours the E6 and E7 oncogenes is usually truncated and lacks the 3Ј-terminal part with the poly(A) signal (Schwarz et al., 1985) . Therefore, transcription initiated at the viral early promoter continues into the flanking cellular sequences, and RNA processing results in multiply spliced fusion transcripts composed of 5Ј-terminal viral sequences with the E6 and E7 oncogenes and 3Ј-terminal co-transcribed cellular sequences (Schneider-Gädicke and Schwarz, 1986) .
Besides affecting the expression of the viral oncogenes, the integration event may also cause alterations of cellular genes within the target region. For example, integration of HPV DNA near myc genes has been reported to enhance the proto-oncogene expression (Couturier et al., 1991) . (A) The genomic DNA was cleaved with SacI, and the filters were hybridized either with probe 2.5, a 2.5 kb SacI-BamHI fragment containing the left flanking cellular sequences, or with probe 3.5, a 3.5 kb BamHI-SacI fragment containing the right flanking cellular sequences. (B) The genomic DNA was cleaved with HindIII, and the filter was hybridized with probe 2.5. Lane M in (A) and the bars in (B) indicate the positions of the λ HindIII size marker fragments. The names of the cell lines are given above the lanes. DNA isolated from a biopsy of normal human placenta was also included.
Since the integrated HPV DNA is a tag for the chromosomal target region, it may also provide a useful tool for the identification of novel cancer-relevant cellular genes (Kahn et al., 1996) . In the present study, we have analysed in the human cervical carcinoma cell line ME180 the cellular target region of the integrated HPV DNA (Reuter et al., 1991) which has meanwhile been classified as an HPV68 subtype (Longuet et al., 1996) . We report here the identification of a novel human gene, APM-1, which is present in the viral-cellular fusion transcripts due to co-transcription with the HPV68 E6 and E7 genes. The APM-1 gene encodes a protein with zinc fingers and a BTB/POZ domain that exerts the activities of a cell growth inhibitor.
Results
Homozygosity of the mutant allele carrying the integrated HPV68 DNA in the cell line ME180 From a genomic DNA library of the cell line ME180, the integrated HPV68 DNA had previously been isolated together with flanking cellular sequences at both sides (Reuter et al., 1991) . To examine the cellular target region of HPV68 DNA integration, the cloned flanking cellular sequences were used as radiolabelled probes in genomic Southern blot hybridizations (Figure 1) . Remarkably, the hybridization patterns of ME180 DNA revealed homozygosity of the mutant allele carrying the integrated HPV68 DNA, a result suggesting that loss of heterozygosity has occurred after the HPV DNA integration event. Since allele loss is characteristic for loci harbouring tumour suppressor genes (Knudson, 1993) , we speculated that the cellular target region of HPV68 DNA integration might harbour a tumour suppressor gene.
Transcribed human sequences in the target region of HPV68 integration
To search for the suspected gene, we first examined by Northern blot analysis whether the cloned cellular sequences flanking the integrated HPV68 DNA hybridize with human mRNAs. Since this was not the case (data not shown), we isolated the genomic region encompassing the ME180-specific site of HPV68 DNA integration from a cosmid library of normal human leukocyte DNA. One cosmid clone, designated INT68 (because it contains the chromosomal target site of HPV68 DNA integration), was used for the further analyses.
To examine whether the cosmid insert harbours transcribed sequences, Northern hybridizations with the radiolabelled INT68 DNA probe were performed (Figure 2 ). In ME180 poly(A) ϩ -RNA, the cosmid probe produced very strong hybridization signals which were indistinguishable from the signals produced with an HPV68 E6/E7 probe (not shown). In the poly(A) ϩ -RNAs of the other cell lines tested, two transcripts of~4 kb and~3 kb length were detected. These results indicated first, that the cosmid INT68 includes sequences that are co-transcribed with the HPV68 genes E6 and E7 to produce the viral-cellular fusion transcripts in ME180 cells, and second, that the cosmid INT68 harbours sequences that are transcribed in other cell lines in the absence of integrated HPV68 DNA and thus should be integral parts of authentic cellular mRNAs.
To localize the transcribed sequences within the cosmid insert, the INT68 DNA was dissected into SacI fragments which were used as individual probes in Northern hybridizations. The viral-cellular fusion transcripts of ME180 cells hybridized with a SacI fragment of 5.5 kb (not shown) which was subsequently cloned and partially sequenced (see Figure 4B for the SacI map of cosmid INT68). Comparison of the partial sequences with the database-stored sequences revealed that the fragment contains sequence motifs with the potential to encode Cys 2 -His 2 zinc fingers of the Krueppel type. The INT68 zinc finger sequences were not identical with any of the already known human zinc finger-encoding genes. Furthermore, a 0.5 kb subfragment containing the zinc finger motifs also hybridized with the fusion transcripts of ME180 cells (not shown). These results indicated that a novel human gene encoding a zinc finger protein is located in the INT68 region and is co-transcribed with the HPV68 E6 and E7 genes in ME180 cells. We named the human gene APM-1 to indicate that its transcription is affected by papillomavirus DNA integration in ME180 cells.
Fusion transcript structure and exon-intron composition of the human APM-1 gene
To characterize the ME180-specific fusion transcripts, more than 20 positive clones were isolated from a ME180 cDNA library and were structurally characterized by PCR and hybridization analysis. The results indicated that the co-transcribed cellular sequences of all cDNA clones are identical, and that the transition from the 5Ј-viral into the 3Ј-co-transcribed cellular sequences occurs in all cDNA clones at a splice donor located at the beginning of HPV68 ORF E1.
One representative cDNA clone, Mefust-4, was selected for complete sequence analysis. According to the nucleotide sequence, the fusion transcript contains a 5Ј-terminal HPV68 segment of 839 bp with the early genes E6 and E7 followed by a 3Ј-terminal cellular segment of 3779 bp. The cellular part includes an open reading frame with the 217 coding potential for a protein of 619 amino acid residues ( Figure 3A ). The deduced protein contains four Krueppeltype Cys 2 -His 2 zinc fingers, of which two-and-a-half are encoded in the 0.5 kb subfragment of the 5.5 kb SacI fragment of cosmid INT68. These results show that the ORF in the co-transcribed cellular part of the fusion transcripts harbours the APM-1 gene.
Computer-based alignment analysis revealed that the N-terminus of the deduced APM-1 protein shows strong similarity to a conserved motif called the BTB or POZ domain ( Figure 3B ). The BTB/POZ domain is a newly characterized motif of~120 amino acid residues which is evolutionary conserved, primarily found at the N-terminus of zinc finger proteins, and involved in protein-protein interactions (Bardwell and Treisman, 1994; Albagli et al., 1995; Chen et al., 1995) . The ATG triplet located 17 bp downstream of the viral-cellular exon junction can be assigned as the potential translational start codon of the APM-1 gene based on the sequence alignment and because it is in a good sequence context for translational initiation according to the Kozak rules (Kozak, 1996) . The BTB/POZ domain is followed by a highly acidic region ( Figure 3A) .
Comparison of the cDNA sequence with the partial and complete nucleotide sequences of the genomic SacI fragments 5.5 kb and 4.5 kb (4.5a) and of the adjacent terminus of the 3.3 kb fragment allowed identification of the exon junctions in the fusion transcript cDNA and the exon locations within cosmid INT68. The results are summarized in Figure 4 . The cDNA clone Mefust-4 includes a 3Ј-terminal A 20 stretch. Fifteen of these A-residues are found in the respective genomic sequence, followed by a potential polyadenylation signal AATAAA and a potential splice donor sequence. These data indicate that the fusion transcripts may either be terminated at this polyadenylation signal or, alternatively, may contain an additional 3Ј-untranslated exon.
APM-1 transcript patterns
To analyse expression of the APM-1 gene, Northern analyses with poly(A) ϩ -RNA from cervical carcinoma cell lines and cultured normal cervical epithelial cells were performed. Figure 5 gives a synopsis of the results. Using various subfragments of the INT68 genomic segment and of the Mefust-4 cDNA as radiolabelled probes (depicted in Figure 5 , panels k and l), altogether three cellular mRNA species with sizes of~5 kb, 4 kb and 3 kb, respectively, were detected in the cell lines that do not harbour the integrated HPV68 DNA. The different hybridization profiles indicate that the 5 kb transcript is 218 the most relevant of these three mRNA species with regard to the APM-1 gene. Poly(A) ϩ -RNA of the lung carcinoma cell line LX-1 was included in the Northern experiments as a positive control, since the 5 kb mRNA was discernible in this cell line with a strong hybridization signal. One important feature of the 5 kb mRNA is that it hybridized with all the different cDNA probes derived from the APM-1 coding region and the 3Ј-untranslated part ( Figure  5 , panels d-i). These hybridization properties indicate that the exons 2 and 3 of the fusion transcript are present in identical form in the cellular 5 kb mRNA. We concluded that the 5 kb transcript is the authentic cellular mRNA for the APM-1 gene. Another feature of the 5 kb transcript is the restricted presence in the cervical carcinoma cell lines. The 5 kb mRNA was detectable in the cultured normal cervical keratinocytes ( Figure 5, panel i) , but in only two out of the 11 cell lines tested (C4-II and MRI-H196; Figure 5 , panels d, h and i). The levels of the 5 kb mRNA in the normal cervical cells and the two carcinoma cell lines are much lower than in the LX-1 cell line.
The two other mRNA species, with sizes of~3 kb and 4 kb, differ in two important aspects from the 5 kb APM-1 mRNA. First, they seem to be ubiquitously present, in particular the 4 kb species. Second, they did not hybridize with the second APM-1 coding exon (probes c and g) or the BTB/POZ domain segment (probe e), but only with a probe containing the 3Ј-part of the first APM-1 coding exon (probe f). These hybridization properties suggest that the 3 kb and 4 kb transcripts do not harbour the complete coding region of the APM-1 gene and the 3Ј-untranslated part. It should be mentioned here that the cellular mRNAs detected with the INT68 cosmid probe in the initial Northern analysis (see Figure 2) are the 4 kb and 3 kb transcripts.
For additional analysis of the cellular APM-1 mRNAs, we used cosmid INT68 to employ a strategy for cosmidspecific selection of cDNA clones (Korn et al., 1992 (Korn et al., , 1997 . Sixteen cDNA clones with insert sizes ranging between 150 bp and 924 bp were isolated and sequenced (data not shown). Six cDNAs were derived from human fetal liver, 10 from fetal brain, but none from adult skeletal muscle. In most cases, the nucleotide sequences of the cDNA inserts were identical to the respective parts of the APM-1 sequences present in the ME180 fusion transcripts. Interestingly, in one liver cDNA clone the first APM-1 coding exon (i.e. exon 2 of the fusion transcript) is preceded by a 5Ј-terminal sequence of 127 bp which probably constitutes part of a 5Ј-non-coding exon of the cellular APM-1 mRNA (not shown). The 127 bp segment did not hybridize with the INT68 cosmid DNA (not shown).
Chromosomal localization of the HPV68 integration site and of the APM-1 gene
To determine the chromosomal localization of the HPV68 integration site and of the APM-1 gene, fluorescence in situ hybridizations to metaphase chromosomes of normal human cells and ME180 cells were performed. Hybridization of the biotin-labelled INT68 cosmid probe to normal human metaphase chromosomes and banding of the chromosomes by DAPI revealed the specific localization of the target sequences on the long arm of chromosome 18 within band 18q21 (Figure 6 ).
The copy number of the viral integration locus in ME180 cells was assessed by dual colour fluorescence in situ hybridization with the biotin-labelled INT68 cosmid and a digoxigenin-labelled HPV68 restriction fragment. In the analysed metaphase cells, two copies of chromosome 18 were found which contain the human genomic DNA of the integration site and the viral sequences. The highly specific co-localization of both sequences is illustrated in Figure 6 . No INT68 sequences without co-localization with HPV68 DNA were found. These data demonstrate that ME180 cells contain two copies of the mutant chromosome 18 harbouring the integrated HPV68 DNA, and lack copies of the normal (unoccupied) chromosome 18.
Effect of APM-1 on cell growth
The present study was initiated by the speculation that a cellular tumour suppressor gene might be located in the genomic target region of HPV68 DNA integration in the cell line ME180. We tested this assumption for the identified APM-1 gene using a colony formation assay. After inserting the APM-1 gene and the complete fusion transcript cDNA, Mefust, into the eukaryotic expression vector pSG5, each of the expression constructs was cotransfected with the G418 selection plasmid pSV2-neo into cells of the HeLa and CaSki cervical carcinoma cell lines, both of which do not contain detectable amounts of the endogenous APM-1 transcript (see Figure 5) . The pSG5 vector alone and the cDNA antisense construct were used as controls. The results of the colony formation assays are shown in Figure 7 . The clonal growth of both HeLa and CaSki cells was strongly reduced by the transfected APM-1 expression plasmid. Compared with the pSG5 control, the Mefust fusion transcript cDNA also exerted a growth inhibitory effect which, however, was weaker than that of the APM-1 construct and was comparable with the effect of the antisense construct. The results indicate that the APM-1 gene encodes a protein with growth inhibitory activity for cervical carcinoma cell lines. (1), the expression plasmid pSG5-APM-1 using two different DNA preparations (2, 3), the antisense construct pSG5-APM-1-as (4), or the expression plasmid pSG5-Mefust (5). Two additional independent experiments were performed with HeLa cells and one additional experiment with CaSki cells. All experiments yielded comparable results. Transfection efficiency was controlled by co-transfection of the pCMV-gal plasmid and measurement of β-galactosidase activity.
Discussion
In this study we report the identification of a novel human gene, APM-1, that is aberrantly co-transcribed with HPV68 E6 and E7 genes in the cervical carcinoma cell line ME180 due to integration of the papillomavirus DNA into the gene locus. The APM-1 gene is localized in region q21 of chromosome 18 and encodes a zinc finger protein with an N-terminal BTB/POZ domain. In transfection assays, the APM-1 gene product showed the potential to reduce tumour cell proliferation in vitro.
From the structures of the cDNAs and the genomic DNA, we deduce that the HPV68 DNA is integrated into an intron that separates the 5Ј-untranslated exon(s) from the first coding exon of the APM-1 gene. As a consequence, the protein-encoding part of the APM-1 gene is separated from the promoter region, and transcription is placed under control of the early promoter of the integrated HPV68 DNA. A hallmark of the mature fusion transcripts is their polycistronic structure with the viral E6 and E7 genes and the cellular APM-1 gene being present as separate cistrons ( Figure 4A ). Eukaryotic mRNAs are usually monocistronic, and initiation of translation is generally restricted to the first AUG start codon downstream of the 5Ј-cap (Kozak, 1996) . In the fusion transcripts the AUG codon of the APM-1 gene is preceded by the AUG codons of the three viral genes E6, E7 and E1 which are all in a good or adequate sequence context for initiation of translation according to the Kozak rules (Kozak, 1996) . These structural features suggest that translation of the APM-1 gene from the fusion transcripts may be inefficient or even impossible. With regard to expression of the APM-1 gene in the ME180 cell line, integration of HPV68 DNA might thus have created an apparently paradoxical situation in which efficient transcription from the viral promoter and high fusion transcript levels actually create underexpression.
The human APM-1 gene as present in the fusion transcripts encodes a protein with an amino-terminal BTB/ POZ domain and four C 2 H 2 zinc fingers of the Krueppel type. These two structural features define the APM-1 gene as a novel member of the subfamily of genes encoding Krueppel-like zinc finger proteins with a BTB/POZ domain. The BTB (for Broad Complex, tramtrack and bric à brac) or POZ (for poxvirus and zinc finger) domain has originally been defined in products of Drosophila genes involved in developmental regulation and in poxvirus proteins (Bardwell and Treisman, 1994; Zollman et al., 1994; Albagli et al., 1995) . It has been characterized as a domain that mediates homomeric or heteromeric protein-protein interactions (Bardwell and Treisman, 1994; Chen et al., 1995) , that targets the protein to distinct nuclear substructures , and that is involved in transcriptional regulation or chromatin modelling (Albagli et al., 1995; Chang et al., 1996; Seyfert et al., 1996) .
Three human members of the BTB/POZ subfamily of zinc finger-encoding genes are known to be involved in carcinogenesis. Expression of the bcl-6 proto-oncogene is deregulated by chromosomal translocations in diffuse large-cell lymphoma (Ye et al., 1995) . The PLZF gene is fused to the retinoic acid receptor α-encoding gene in a small subset of acute promyleocytic leukaemias (Dong et al., 1996) . The HIC-1 gene has been identified recently by its underexpression in tumour cells due to hypermethylation and is viewed as a candidate tumour suppressor gene (Makos Wales et al., 1995) .
The homozygosity of the mutant allele which carries the integrated HPV68 DNA in ME180 cells, as revealed by genomic Southern analysis (Figure 1 ), was initially taken as a hint for the existence of a tumour suppressor gene within the integration region. The ability of the APM-1 gene to reduce the clonal growth of HeLa and CaSki cervical carcinoma cells in vitro (Figure 7 ) argues in favour of the assumption that the APM-1 gene might be the postulated tumour suppressor gene. Furthermore, fluorescence in situ hybridization on metaphase chromosomes revealed that ME180 cells contain two copies of the mutant chromosome 18 harbouring the integrated HPV68 DNA and completely lack the normal chromosome 18. This situation probably resulted after the HPV integration event from the loss of the remaining normal copy and duplication of the mutant copy. Due to these genetic changes, the APM-1 gene is present in ME180 cells only in the mutated form.
An~5 kb transcript could be identified as the authentic cellular APM-1 mRNA ( Figure 5 ). The Northern blot analyses indicate that the APM-1 gene is expressed in normal cervical epithelial cells, but that it is not expressed or underexpressed in the majority of the cervical carcinoma cell lines analysed. Southern blot analysis gave no indication for a loss of the APM-1 gene in any of the cell lines with undetectable 5 kb mRNA (see Figure 1) . Altogether, these data suggest that loss or reduction of APM-1 gene expression might occur during cervical carcinogenesis and further support the assumption of a tumour suppressor role of the APM-1 gene. It will be of interest to determine whether alterations in APM-1 gene expression can also be detected in other types of human carcinomas.
Besides the 5 kb APM-1 mRNA, two other transcripts of~3 kb and 4 kb are produced from the INT68 genomic region (Figures 2 and 5) . In contrast to the restricted presence of the APM-1 mRNA, these two transcriptsand in particular the 4 kb species-are almost ubiquitously detected. The two transcripts hybridize only with the 3Ј-part of the first APM-1 coding exon. Their exact structures and coding informations have yet to be determined, and the question whether they have the same or the opposite orientation with regard to the APM-1 mRNA remains to be answered.
We have mapped the APM-1 gene to chromosome 18q21 (Figure 6 ). This genomic region seems to be involved in human carcinogenesis in multiple ways. For example, it harbours the tumour suppressor genes DCC and DPC4 which are deleted in colorectal and pancreatic cancers, respectively (Cho and Fearon, 1995; Hahn et al., 1996) . Allele losses at 18q21 have also been reported for an HPV16-positive oral carcinoma and its derived cell line (Steenbergen et al., 1995) and for an HPV18-immortalized keratinocyte line (Klingelhutz et al., 1993) . It is evident from genetic studies that genes other than the already identified candidate tumour suppressor genes are involved in allele losses at 18q21 (Hahn et al., 1996) . Here the APM-1 gene provides a novel candidate and marker gene.
In this study we provide direct evidence that the integration of HPV DNA can alter the integrity and expression of cellular genes located in the chromosomal target region. Furthermore, we show that the integrated HPV DNA can serve as a marker for the identification of novel human genes that are themselves possibly involved in carcinogenesis. Future studies will clarify the possible functions of the APM-1 protein in the regulation of transcription or chromatin folding, and the importance of APM-1 gene alterations in human cancer.
Materials and methods

Cell lines, primary cells and cell culture conditions
The human cervical carcinoma cell lines CaSki, C4-I, C4-II, C33A, HeLa, HT-3, ME180, MS751 and SiHa were obtained from the American Type Culture Collection, the non-tumorigenic HeLaϫnormal human fibroblast hybrid cell line 444 from E.Stanbridge (Irvine, USA), the immortalized keratinocyte line HaCaT from P.Boukamp (DKFZ, Heidelberg), the lymphoblastoid cell line IARC277 from M.Pawlita (DKFZ), and the cervical carcinoma cell lines MRI-H186, MRI-H196 and MRI-H215 as well as the lung carcinoma cell line LX-1 from H.Löhrke (Tumorbank, DKFZ). The primary ectocervical keratinocytes were derived from a cervical biopsy obtained from hysterectomy. The established cells and the primary cells were cultivated as described previously (Geisen et al., 1997) .
Recombinant plasmids
Plasmid pCMV-Gal contains the Escherichia coli β-galactosidase gene driven by the CMV promoter. The eukaryotic expression vector pSG5 containing the SV40 early promoter was obtained from Stratagene (Heidelberg, Germany). Plasmid pSV2-neo harbours the neo gene conferring resistance to the antibiotic G418. The expression plasmid pSG5-Mefust was constructed by inserting the complete fusion transcript cDNA of clone Mefust-4 into the EcoRI-digested pSG5 vector. The APM-1 gene, together with the 3Ј-untranslated region, was prepared from Mefust-4 cDNA by cleavage with MunI and EcoRI. The fragment was inserted into pSG5 in sense and antisense orientation to yield the expression plasmid pSG5-APM-1 and the antisense construct pSG5-APM-1-as, respectively.
DNA and RNA analysis
Total high-molecular weight DNA was isolated from cells by proteinase K digestion and phenol extraction. DNAs digested with restriction enzymes were separated electrophoretically on 0.8% agarose gels, and transferred to Hybond N ϩ membranes (Amersham Buchler, Braunschweig, Germany). Total RNA was isolated from cells by the acidic guanidinium isothiocyanate procedure (Chomczynski and Sacchi, 1987) . Poly(A) ϩ -RNA was selected using dynabeads oligo(dT) 25 (Dynal, Hamburg, Germany) . RNAs were denatured, fractionated in 1% agarose gels and transferred to Hybond N ϩ membranes using 10ϫ SSC-buffer. The DNA probes were labelled with 32 P by random priming (Stratagene, Heidelberg, Germany). Filter hybridization and washing were done essentially as described (Geisen et al., 1997) . In Southern and Northern hybridizations with genomic probes, preincubations of the probes with human Cot-1 DNA (Gibco-BRL, Eggenstein, Germany) were performed to block hybridization of the repetitive sequences.
Isolation of cosmid clones
To isolate the human genome region corresponding to the integration region of HPV68 DNA in the cell line ME180, we used a cosmid library of normal human leukocyte DNA (Poustka et al., 1984) distributed on seven plates containing 2-3ϫ10 5 clones each. In a first screening, a Southern filter with DNA of the seven fractions was hybridized with the flanking cellular sequences of the integrated HPV68 DNA as labelled probe. The filters of the positive fractions were then hybridized, and positive clones were isolated and purified.
cDNA cloning A fusion transcript cDNA product of 1338 bp was amplified by reverse transcription of ME180 poly(A) ϩ -RNA and hot start PCR using a primer in sense orientation from the HPV68 E1 region (5Ј-CAATGGCCAA-TTGTGAAG-3Ј) in combination with an antisense primer from the cellular zinc finger-encoding region of the genomic 5.5 kb SacI fragment (5Ј-TCGTAGTTGTGCACGAACTTGG-3Ј). A ME180 cDNA library in phage λNM1149 was kindly prepared by H.Sommer (Max-PlanckInstitut für Züchtungsforschung, Cologne, Germany). Positive clones were identified by plaque hybridization with the 1338 bp RT-PCR product as radiolabelled probe.
Cosmid-specific selection of cDNA clones Cosmid INT68 was used to enrich cDNA clones derived from this region of the human genome. The selection was performed as described (Korn et al., 1992 (Korn et al., , 1997 . In brief, the biotinylated cosmid DNA was hybridized to cDNA inserts which had been amplified by PCR from three cDNA libraries derived from fetal human brain, fetal human liver and adult skeletal muscle, respectively. Filters carrying the enriched cDNA collection were hybridized with the 1338 bp RT-PCR product as probe. The presence of identification markers in the terminal adapter sequences of the enriched cDNAs allowed identification of the origin of each cDNA insert.
Determination and computer analysis of genomic and cDNA sequences DNA sequencing was performed by the dideoxy chain termination method using a primer walking approach. Dideoxynucleotide incorporation into the sequencing products was improved by the use of a manganesecontaining buffer (Tabor and Richardson, 1989) . Computer analysis of the nucleotide sequences and derived amino acid sequences were done using self-written software and the program package of the Heidelberg Unix Sequence Analysis Resources (HUSAR) program library.
The nucleotide sequence data have been submitted to the DDBJ/ EMBL/GenBank database under accession numbers Y14591 (cDNA sequence), Y14592 (4.5 kb SacI fragment of cosmid INT68) and Y14593 (partial sequence within the 5.5 kb SacI fragment of cosmid INT68).
Fluorescent in situ hybridization of chromosomes
Chromosomes were prepared from peripheral blood of a normal individual or from the cell line ME180 following standard protocols. Cosmid INT68 was labelled with biotin, whereas a 4 kb SpeI fragment of HPV68 DNA and the chromosome 18-specific alphoid DNA probe L1.84 (Devilee et al., 1986) were labelled with digoxigenin by nick translation before hybridizing to metaphase chromosomes as described (Lichter et al., 1990) . Briefly, labelled probe (60 ng) was combined with human Cot-1 DNA (3 μg) and salmon sperm DNA (7 μg) and was hybridized at 37°C overnight. Following post-hybridization washes, the biotinlabelled probe was detected via avidin conjugated to FITC and the digoxigenin-labelled probes via anti-digoxigenin antibodies conjugated to rhodamine. Chromosomes were banded with 4,6-diamidino-2-phenylindole-dihydrochloride (DAPI). Digitized images of FITC, rhodamine or DAPI fluorescence were recorded separately with a CCD camera (Photometrics, Tucson, Arizona, USA), electronically overlayed, carefully aligned and pseudocoloured. Photographs were taken from the monitor.
Colony formation assay
Cells were seeded into 10 cm dishes at a density of 2.5ϫ10 5 cells per dish 24-48 h before transfection. The transfection was performed with a mixture of 19 μg effector or control DNA and 1 μg pSV2-neo DNA per dish. Medium containing G418 at a concentration of 800 μg/ml (CaSki cells) or 1000 μg/ml (HeLa cells) was added 1 day after transfection to select for G418-resistant cells. G418-containing medium was changed every third day. After 2 weeks of selection, the cells were stained and colonies (Ͼ8 cells) were counted to determine clonal cell growth. For each plasmid DNA, transfections were done in triplicate.
